Table 3 Laboratory parameters and disease activity of untreated TA patients with positive or negative ASO
|  | ASO positive n = 13 | ASO negative n = 61 | P-Value |
|---|---|---|---|
WBC(109/L) | 7.0 ± 1.5 | 7.3 ± 2.2 | 0.643 |
NE(109/L) | 4.7 ± 1.4 | 4.7 + 1.7 | 0.979 |
LY(109/L) | 1.9 ± 0.6 | 2.1 ± 0.8 | 0.391 |
RBC(1012/L) | 4.51 ± 0.41 | 4.5 ± 0.5 | 0.812 |
Hb (g/L) | 122.8 ± 21.9 | 124.2 ± 19.3 | 0.809 |
PLT(109/L) | 278.6 ± 107.2 | 265.4 ± 90.1 | 0.645 |
ALT (U/L) | 13.7 ± 10.5 | 18.2 ± 14.3 | 0.289 |
Cr (μmol/l) | 63.1 ± 12.8 | 61.2 ± 31.1 | 0.833 |
GLU (mmol/l) | 5.0 ± 0.6 | 5.2 ± 1.1 | 0.612 |
HCY (μmol/l) | 11.5 ± 3.5 | 13.9 ± 9.5 | 0.388 |
RF (IU/ml) | 6.5 (4.0,10.6) | 5.2 (3.1,11.7) | 0.222 |
IL-6 (pg/ml) | 16.2 (3.3, 29.4) | 5.1 (2.3, 12.5) | 0.157 |
TNF-α (pg/ml) | 9.6 (5.8, 22.6) | 20.3 (7.7, 48.7) | 0.210 |
IgA (g/L) | 3.2 ± 1.4 | 2.5 ± 1.3 | 0.086 |
IgG (g/L) | 16.6 ± 4.1 | 12.9 ± 3.7 | 0.002 |
IgM (g/L) | 1.5 ± 0.6 | 1.4 ± 1.0 | 0.823 |
IgE (g/L) | 35.6 (14.3, 176.7) | 17.0 (9.7, 87.3) | 0.151 |
C3 (g/L) | 1.3 ± 0.3 | 1.2 ± 0.2 | 0.188 |
C4 (g/L) | 0.2 ± 0.1 | 0.2 ± 0.1 | 0.657 |
ESR (mm/1 h) | 23.0 (9.0, 72.0) | 18.0 (8.0, 39.0) | 0.352 |
CRP (mg/L) | 4.5 (1.8, 23.6) | 2.2 (0.4, 21.5) | 0.334 |
Kerr Score | 2.5 ± 0.7 | 2.4 ± 0.7 | 0.484 |
ITAS | 8.9 ± 6.0 | 8.2 ± 4.8 | 0.682 |